This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Corrado, D. Articles by Thiene, G. Search for Related Content PubMed PubMed Citation Articles by Corrado, D. Articles by Thiene, G. Pubmed/NCBI databases Medline Plus Health Information Cardiomyopathy Related Collections Myocardial cardiomyopathy disease Arrhythmias, clinical electrophysiology, drugs Genetics of cardiovascular disease Related Article

(Circulation. 2006;113:1634-1637.)
© 2006 American Heart Association, Inc.

Editorial

Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

Clinical Impact of Molecular Genetic Studies

Domenico Corrado, MD, PhD; Gaetano Thiene, MD

From the Department of Cardiac, Thoracic, and Vascular Sciences (D.C.) and Institute of Pathological Anatomy (G.T.), University of Padua Medical School, Padua, Italy.

Correspondence to Domenico Corrado, MD, PhD, Department of Cardiac, Thoracic, and Vascular Sciences, Via Giustiniani 2, 35121 Padova, Italy. E-mail domenico.corrado@unipd.it

Key Words: Editorials • arrhythmia • cardiomyopathy • death, sudden • genetics

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited heart muscle disease that predominantly affects the right ventricle (RV). It is characterized pathologically by RV myocardial atrophy with fibrofatty replacement and clinically by ventricular electric instability with ventricular tachycardia or ventricular fibrillation that may lead to sudden death, primarily in young people and athletes.¹ Later in the disease evolution, progression of RV muscle disease and left ventricular involvement may result in heart failure.² The condition was initially believed to be a developmental defect of the RV myocardium, leading to the original designation of "dysplasia." This concept has evolved over the last 25 years into the current perspective of a genetically determined "cardiomyopathy."³ Clinical diagnosis of ARVC/D is often difficult because of the nonspecific nature of disease features and the broad spectrum of phenotypic manifestations. The advent of the molecular genetic era has provided new insights in understanding the pathophysiology of ARVC/D, showing that it is a desmosomal disease resulting from defective cell adhesion proteins such as plakoglobin, desmoplakin, plakophilin-2, and desmoglein-2.^4–7 The availability of molecular testing for mutation screening of disease genes offers the possibility to identify genetically affected individuals. Potential clinical impact of genotype determination includes diagnosis (family screening and preclinical diagnosis); prediction of clinical phenotype (penetrance, gene-specific clinical manifestations); risk stratification (assessment of malignant versus benign mutations); clinical and genetic counseling (restriction of physical activity, family planning); and therapy (prevention of sudden death by implantable cardioverter/defibrillator [ICD]).

Articles p 1641 and p 1650

In this issue of Circulation, . . . [Full Text of this Article]

Related Article:

Issue Highlights
Circulation 2006 113: 1633. [Extract] [Full Text]

This article has been cited by other articles:

				S. Gupta, T. Baman, and S. M. Day Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening Sports Health: A Multidisciplinary Approach, November 1, 2009; 1(6): 500 - 507. [Abstract] [Full Text] [PDF]

				A. D. den Haan, B. Y. Tan, M. N. Zikusoka, L. I. Llado, R. Jain, A. Daly, C. Tichnell, C. James, N. Amat-Alarcon, T. Abraham, et al. Comprehensive Desmosome Mutation Analysis in North Americans With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Circ Cardiovasc Genet, October 1, 2009; 2(5): 428 - 435. [Abstract] [Full Text] [PDF]

				D. Corrado, C. Basso, M. Schiavon, A. Pelliccia, and G. Thiene Reply J. Am. Coll. Cardiol., June 16, 2009; 53(24): 2309 - 2310. [Full Text] [PDF]

				D. Corrado, C. Basso, and G. Thiene Arrhythmogenic right ventricular cardiomyopathy: an update Heart, May 1, 2009; 95(9): 766 - 773. [Full Text] [PDF]

				M. Pieroni, A. Dello Russo, F. Marzo, G. Pelargonio, M. Casella, F. Bellocci, and F. Crea High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy differential diagnosis by electroanatomic mapping-guided endomyocardial biopsy. J. Am. Coll. Cardiol., February 24, 2009; 53(8): 681 - 689. [Abstract] [Full Text] [PDF]

				D. Corrado, C. Basso, A. Pelliccia, and G. Thiene CHAPTER 32 Sports and Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				R. F. Padera Jr. and F. J. Schoen Pathology of Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 111 - 178. [Full Text]

				S. Sen-Chowdhry, P. Syrris, and W. J. McKenna Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1813 - 1821. [Abstract] [Full Text] [PDF]

				S. Sen-Chowdhry, P. Syrris, D. Ward, A. Asimaki, E. Sevdalis, and W. J. McKenna Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression Circulation, April 3, 2007; 115(13): 1710 - 1720. [Abstract] [Full Text] [PDF]